KAHR Medical Ltd.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Sep 2031
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Aug 13, 2027The maintenance fee for SIRPalpha-41BBL fusion protein and methods of use thereof (US 11,897,937) comes due Aug 13, 2027. Unpaid by Feb 14, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 23, 2026
- Nov 3 US 12,780,894 PD1-41BBL Fusion Protein and Methods of Use Thereof
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,000,549 | Compositions and Methods for Treatment of Hematological Malignancies In force · High confidence | In force | High confidence | |
| US 10,040,841 | Stable form of signal converting protein fusion proteins, and methods of use and preparation thereof In force · USPTO record | In force | USPTO record | |
| US 11,130,796 | SIRPalpha-41BBL fusion protein and methods of use thereof In force · USPTO record | In force | USPTO record | |
| US 11,897,937 | SIRPalpha-41BBL fusion protein and methods of use thereof In force · USPTO record | In force | USPTO record | |
| US 12,331,098 | SIRPalpha-41BBL fusion protein and methods of use thereof In force · USPTO record | In force | USPTO record | |
| US 11,299,530 | SIRP alpha-CD70 fusion protein and methods of use thereof In force · USPTO record | In force | USPTO record | |
| US 12,134,638 | SIRPalpha-4-1BBL VARIANT FUSION PROTEIN AND METHODS OF USE THEREOF In force · High confidence | In force | High confidence | |
| US 11,702,458 | PD1-41BBL Fusion Protein and Methods of Use Thereof In force · Medium confidence | In force | Medium confidence | |
| US 12,780,894 | PD1-41BBL Fusion Protein and Methods of Use Thereof In force · Medium confidence | In force | Medium confidence | |
| US 11,566,060 | PD1-CD70 Fusion Protein and Methods of Use Thereof In force · High confidence | In force | High confidence |
Also on record, not counted in the 11: 1 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
6 pending · 2 abandoned · 4 no status recorded